blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2959020

EP2959020 - METHOD TO SELECT RARE CLONOTYPES [Right-click to bookmark this link]
Former [2016/01]RARE CLONOTYPES AND USES THEREOF
[2018/41]
StatusNo opposition filed within time limit
Status updated on  24.07.2020
Database last updated on 17.07.2024
FormerThe patent has been granted
Status updated on  16.08.2019
FormerGrant of patent is intended
Status updated on  11.04.2019
FormerExamination is in progress
Status updated on  17.01.2019
FormerGrant of patent is intended
Status updated on  26.09.2018
FormerExamination is in progress
Status updated on  22.12.2017
Most recent event   Tooltip08.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 10.08.2022  [2022/32]
Applicant(s)For all designated states
Adaptive Biotechnologies Corporation
1551 Eastlake Avenue East
Suite 200
Seattle, Washington 98102 / US
[2016/10]
Former [2016/01]For all designated states
Sequenta, Inc.
400 East Jamie Court, Suite 301
South San Francisco, CA 94080 / US
Inventor(s)01 / PEPIN, Francois
c/o Adaptive Biotechnologies
329 Oyster Point Blvd
Suite 100
South San Francisco, CA 94080 / US
02 / FAHAM, Malek
c/o Adaptive Biotechnologies
329 Oyster Point Blvd
Suite 100
South San Francisco, CA 94080 / US
03 / MOORHEAD, Martin
c/o Adaptive Biotechnologies
329 Oyster Point Blvd
Suite 100
South San Francisco, CA 94080 / US
 [2016/06]
Former [2016/01]01 / PEPIN, Francois
400 East Jamie Court
Suite 301
South San Francisco, CA 94080 / US
02 / FAHAM, Malek
400 East Jamie Court
Suite 301
South San Francisco, CA 94080 / US
03 / MOORHEAD, Martin
400 East Jamie Court
Suite 301
South San Francisco, CA 94080 / US
Representative(s)Boult Wade Tennant LLP
Salisbury Square House
8 Salisbury Square
London EC4Y 8AP / GB
[N/P]
Former [2019/38]Boult Wade Tennant LLP
5th Floor, Salisbury Square House
8, Salisbury Square
London EC4Y 8AP / GB
Former [2016/01]Boult Wade Tennant
Verulam Gardens
70 Gray's Inn Road
London WC1X 8BT / GB
Application number, filing date14754622.020.02.2014
[2016/01]
WO2014US17416
Priority number, dateUS201361768269P22.02.2013         Original published format: US 201361768269 P
US20131383479415.03.2013         Original published format: US201313834794
[2016/01]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2014130685
Date:28.08.2014
Language:EN
[2014/35]
Type: A1 Application with search report 
No.:EP2959020
Date:30.12.2015
Language:EN
The application published by WIPO in one of the EPO official languages on 28.08.2014 takes the place of the publication of the European patent application.
[2015/53]
Type: B1 Patent specification 
No.:EP2959020
Date:18.09.2019
Language:EN
[2019/38]
Search report(s)International search report - published on:AU28.08.2014
(Supplementary) European search report - dispatched on:EP12.01.2017
ClassificationIPC:C12Q1/6809, C12Q1/6858, C12Q1/6869
[2018/41]
CPC:
C12Q1/6858 (EP); C12Q1/6809 (EP); C12Q1/6869 (EP)
C-Set:
C12Q1/6809, C12Q2537/143, C12Q2537/165 (EP);
C12Q1/6858, C12Q2537/143, C12Q2537/165 (EP);
C12Q1/6869, C12Q2537/143, C12Q2537/165 (EP)
Former IPC [2016/01]C12Q1/68, G01N33/48
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2016/01]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:VERFAHREN ZUR AUSWAHL VON SELTENE KLONOTYPEN[2018/41]
English:METHOD TO SELECT RARE CLONOTYPES[2018/41]
French:PROCÉDÉ POUR SÉLECTIONNER DES CLONOTYPES RARES[2018/41]
Former [2016/01]SELTENE KLONOTYPEN UND VERWENDUNGEN DAVON
Former [2016/01]RARE CLONOTYPES AND USES THEREOF
Former [2016/01]CLONOTYPES RARES ET UTILISATIONS DE CEUX-CI
Entry into regional phase06.08.2015National basic fee paid 
06.08.2015Search fee paid 
06.08.2015Designation fee(s) paid 
06.08.2015Examination fee paid 
Examination procedure06.08.2015Examination requested  [2015/53]
08.08.2017Amendment by applicant (claims and/or description)
21.12.2017Despatch of a communication from the examining division (Time limit: M06)
02.07.2018Reply to a communication from the examining division
27.09.2018Communication of intention to grant the patent
15.01.2019Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
12.04.2019Communication of intention to grant the patent
12.08.2019Fee for grant paid
12.08.2019Fee for publishing/printing paid
12.08.2019Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  21.12.2017
Opposition(s)19.06.2020No opposition filed within time limit [2020/35]
Fees paidRenewal fee
26.02.2016Renewal fee patent year 03
27.02.2017Renewal fee patent year 04
27.02.2018Renewal fee patent year 05
27.02.2019Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU20.02.2014
AL18.09.2019
AT18.09.2019
CY18.09.2019
CZ18.09.2019
DK18.09.2019
EE18.09.2019
FI18.09.2019
HR18.09.2019
LT18.09.2019
LV18.09.2019
MC18.09.2019
MK18.09.2019
MT18.09.2019
NL18.09.2019
PL18.09.2019
RO18.09.2019
RS18.09.2019
SE18.09.2019
SI18.09.2019
SK18.09.2019
SM18.09.2019
TR18.09.2019
BG18.12.2019
NO18.12.2019
GR19.12.2019
IS19.01.2020
PT20.01.2020
LU20.02.2020
BE29.02.2020
CH29.02.2020
LI29.02.2020
[2022/32]
Former [2022/27]HU20.02.2014
AL18.09.2019
AT18.09.2019
CY18.09.2019
CZ18.09.2019
DK18.09.2019
EE18.09.2019
FI18.09.2019
HR18.09.2019
LT18.09.2019
LV18.09.2019
MC18.09.2019
MT18.09.2019
NL18.09.2019
PL18.09.2019
RO18.09.2019
RS18.09.2019
SE18.09.2019
SI18.09.2019
SK18.09.2019
SM18.09.2019
TR18.09.2019
BG18.12.2019
NO18.12.2019
GR19.12.2019
IS19.01.2020
PT20.01.2020
LU20.02.2020
BE29.02.2020
CH29.02.2020
LI29.02.2020
Former [2021/12]AL18.09.2019
AT18.09.2019
CZ18.09.2019
DK18.09.2019
EE18.09.2019
FI18.09.2019
HR18.09.2019
LT18.09.2019
LV18.09.2019
MC18.09.2019
NL18.09.2019
PL18.09.2019
RO18.09.2019
RS18.09.2019
SE18.09.2019
SI18.09.2019
SK18.09.2019
SM18.09.2019
BG18.12.2019
NO18.12.2019
GR19.12.2019
IS19.01.2020
PT20.01.2020
LU20.02.2020
BE29.02.2020
CH29.02.2020
LI29.02.2020
Former [2020/52]AL18.09.2019
AT18.09.2019
CZ18.09.2019
DK18.09.2019
EE18.09.2019
FI18.09.2019
HR18.09.2019
LT18.09.2019
LV18.09.2019
MC18.09.2019
NL18.09.2019
PL18.09.2019
RO18.09.2019
RS18.09.2019
SE18.09.2019
SI18.09.2019
SK18.09.2019
SM18.09.2019
BG18.12.2019
NO18.12.2019
GR19.12.2019
IS19.01.2020
PT20.01.2020
LU20.02.2020
CH29.02.2020
LI29.02.2020
Former [2020/50]AL18.09.2019
AT18.09.2019
CZ18.09.2019
DK18.09.2019
EE18.09.2019
FI18.09.2019
HR18.09.2019
LT18.09.2019
LV18.09.2019
MC18.09.2019
NL18.09.2019
PL18.09.2019
RO18.09.2019
RS18.09.2019
SE18.09.2019
SI18.09.2019
SK18.09.2019
SM18.09.2019
BG18.12.2019
NO18.12.2019
GR19.12.2019
IS19.01.2020
PT20.01.2020
LU20.02.2020
Former [2020/48]AL18.09.2019
AT18.09.2019
CZ18.09.2019
DK18.09.2019
EE18.09.2019
FI18.09.2019
HR18.09.2019
LT18.09.2019
LV18.09.2019
NL18.09.2019
PL18.09.2019
RO18.09.2019
RS18.09.2019
SE18.09.2019
SI18.09.2019
SK18.09.2019
SM18.09.2019
BG18.12.2019
NO18.12.2019
GR19.12.2019
IS19.01.2020
PT20.01.2020
LU20.02.2020
Former [2020/37]AL18.09.2019
AT18.09.2019
CZ18.09.2019
DK18.09.2019
EE18.09.2019
FI18.09.2019
HR18.09.2019
LT18.09.2019
LV18.09.2019
NL18.09.2019
PL18.09.2019
RO18.09.2019
RS18.09.2019
SE18.09.2019
SI18.09.2019
SK18.09.2019
SM18.09.2019
BG18.12.2019
NO18.12.2019
GR19.12.2019
IS19.01.2020
PT20.01.2020
Former [2020/36]AL18.09.2019
AT18.09.2019
CZ18.09.2019
DK18.09.2019
EE18.09.2019
FI18.09.2019
HR18.09.2019
LT18.09.2019
LV18.09.2019
NL18.09.2019
PL18.09.2019
RO18.09.2019
RS18.09.2019
SE18.09.2019
SK18.09.2019
SM18.09.2019
BG18.12.2019
NO18.12.2019
GR19.12.2019
IS19.01.2020
PT20.01.2020
Former [2020/27]AL18.09.2019
AT18.09.2019
CZ18.09.2019
EE18.09.2019
FI18.09.2019
HR18.09.2019
LT18.09.2019
LV18.09.2019
NL18.09.2019
PL18.09.2019
RO18.09.2019
RS18.09.2019
SE18.09.2019
SK18.09.2019
SM18.09.2019
BG18.12.2019
NO18.12.2019
GR19.12.2019
PT20.01.2020
IS24.02.2020
Former [2020/25]AL18.09.2019
AT18.09.2019
CZ18.09.2019
EE18.09.2019
FI18.09.2019
HR18.09.2019
LT18.09.2019
LV18.09.2019
NL18.09.2019
PL18.09.2019
RO18.09.2019
RS18.09.2019
SE18.09.2019
SK18.09.2019
BG18.12.2019
NO18.12.2019
GR19.12.2019
PT20.01.2020
IS24.02.2020
Former [2020/23]AL18.09.2019
AT18.09.2019
EE18.09.2019
FI18.09.2019
HR18.09.2019
LT18.09.2019
LV18.09.2019
NL18.09.2019
PL18.09.2019
RO18.09.2019
RS18.09.2019
SE18.09.2019
BG18.12.2019
NO18.12.2019
GR19.12.2019
PT20.01.2020
Former [2020/22]AL18.09.2019
EE18.09.2019
FI18.09.2019
HR18.09.2019
LT18.09.2019
LV18.09.2019
NL18.09.2019
RS18.09.2019
SE18.09.2019
BG18.12.2019
NO18.12.2019
GR19.12.2019
PT20.01.2020
Former [2020/20]AL18.09.2019
FI18.09.2019
HR18.09.2019
LT18.09.2019
LV18.09.2019
NL18.09.2019
RS18.09.2019
SE18.09.2019
BG18.12.2019
NO18.12.2019
GR19.12.2019
Former [2020/15]AL18.09.2019
FI18.09.2019
HR18.09.2019
LT18.09.2019
LV18.09.2019
RS18.09.2019
SE18.09.2019
BG18.12.2019
NO18.12.2019
GR19.12.2019
Former [2020/11]FI18.09.2019
HR18.09.2019
LT18.09.2019
LV18.09.2019
RS18.09.2019
SE18.09.2019
BG18.12.2019
NO18.12.2019
GR19.12.2019
Former [2020/10]FI18.09.2019
LT18.09.2019
SE18.09.2019
BG18.12.2019
NO18.12.2019
Former [2020/09]FI18.09.2019
LT18.09.2019
NO18.12.2019
Former [2020/08]LT18.09.2019
NO18.12.2019
Documents cited:Search[I]  - WU DAVID ET AL, "High-throughput sequencing detects minimal residual disease in acute T lymphoblastic leukemia", SCIENCE TRANSLATIONAL MEDICINE, AAAS - AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE, US, (20120516), vol. 4, no. 134, doi:10.1126/SCITRANSLMED.3003656, ISSN 1946-6242, pages 151 - 157, XP008164047 [I] 1-13 * abstract * * page 1, column r, paragraph last * * page 2, column r * * page 4, column l, paragraph last * * page 4, column r, paragraph 3 *

DOI:   http://dx.doi.org/10.1126/scitranslmed.3003656
 [A]  - C. GAWAD ET AL, "Massive evolution of the immunoglobulin heavy chain locus in children with B precursor acute lymphoblastic leukemia", BLOOD, (20120828), vol. 120, no. 22, doi:10.1182/blood-2012-05-429811, ISSN 0006-4971, pages 4407 - 4417, XP055066136 [A] 1-13 * the whole document *

DOI:   http://dx.doi.org/10.1182/blood-2012-05-429811
 [A]  - R. WINCHESTER ET AL, "Circulating Activated and Effector Memory T Cells Are Associated with Calcification and Clonal Expansions in Bicuspid and Tricuspid Valves of Calcific Aortic Stenosis", THE JOURNAL OF IMMUNOLOGY, US, (20110715), vol. 187, no. 2, doi:10.4049/jimmunol.1003521, ISSN 0022-1767, pages 1006 - 1014, XP055303430 [A] 2-4 * page 1007, column r, paragraph 3 *

DOI:   http://dx.doi.org/10.4049/jimmunol.1003521
 [AP]  - WOODSWORTH DANIEL J ET AL, "Sequence analysis of T-cell repertoires in health and disease.", GENOME MEDICINE 2013, (20131030), vol. 5, no. 10, ISSN 1756-994X, page 98, XP055186034 [AP] 1-13 * the whole document *

DOI:   http://dx.doi.org/10.1186/gm502
International search[X]WO2011139371  (SEQUENTA INC [US], et al);
 [XP]US2013196328  (PEPIN FRANCOIS [US], et al)
by applicantUS5296351
 US5837447
 US6087096
 US2006234234
 EP1544308
 US7537897
    - "U.S.-Canadian consensus recommendations on the immunophenotypic analysis of haematologic neoplasia by flow cytometry", Cytometry, (19970000), vol. 30, pages 214 - 263
    - VAN DONGEN et al., Leukemia, (20030000), vol. 17, pages 2257 - 2317
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.